Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

rTRD01

😃Good
Catalog No. T81251Cas No. 1332175-56-0
Alias rTRD-01, rTRD 01

rTRD01 is a small-molecule TDP-43 ligand that binds the RRM1 and RRM2 domains of TDP-43 and partially disrupts its interaction with the pathogenic hexanucleotide RNA repeat of the c9orf72 gene, supporting the application of rTRD01 in mechanistic studies of RNA binding dysregulation in neurodegenerative disease research.

rTRD01

rTRD01

😃Good
Purity: 99.44%
Catalog No. T81251Alias rTRD-01, rTRD 01Cas No. 1332175-56-0
rTRD01 is a small-molecule TDP-43 ligand that binds the RRM1 and RRM2 domains of TDP-43 and partially disrupts its interaction with the pathogenic hexanucleotide RNA repeat of the c9orf72 gene, supporting the application of rTRD01 in mechanistic studies of RNA binding dysregulation in neurodegenerative disease research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$68-In Stock
5 mg$163-In Stock
10 mg$263-In Stock
25 mg$529-In Stock
50 mg$848-In Stock
100 mg$1,130-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.44%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
rTRD01 is a small-molecule TDP-43 ligand that binds the RRM1 and RRM2 domains of TDP-43 and partially disrupts its interaction with the pathogenic hexanucleotide RNA repeat of the c9orf72 gene, supporting the application of rTRD01 in mechanistic studies of RNA binding dysregulation in neurodegenerative disease research.
In vitro
In biophysical assays using Microscale Thermophoresis, rTRD01 bound to the TDP-43 RRM1-RRM2 construct with a Kd of 89 μM. This interaction modulated TDP-43 binding to specific RNA sequences (UG-rich repeats), preventing aberrant protein-RNA interactions associated with aggregation [1].
In vivo
In flies expressing human TDP-43, which typically display locomotor defects, treatment with rTRD01 led to a reduction in motor dysfunctions [1].
SynonymsrTRD-01, rTRD 01
Chemical Properties
Molecular Weight344.38
FormulaC18H21FN4O2
Cas No.1332175-56-0
SmilesO=C(N)C=1N=C(C=NC1)N2CCCC(CO)(CC3=CC=C(F)C=C3)C2
ColorYellow
AppearanceSolid
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (232.3 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9038 mL14.5188 mL29.0377 mL145.1885 mL
5 mM0.5808 mL2.9038 mL5.8075 mL29.0377 mL
10 mM0.2904 mL1.4519 mL2.9038 mL14.5188 mL
20 mM0.1452 mL0.7259 mL1.4519 mL7.2594 mL
50 mM0.0581 mL0.2904 mL0.5808 mL2.9038 mL
100 mM0.0290 mL0.1452 mL0.2904 mL1.4519 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Stock solution preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (stock solution concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
The above example illustrates how to use "In Vivo Formulation Calculator" and does not represent a recommended formulation for any specific compound. Please select an appropriate dissolution method based on your experimental animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy rTRD01 | purchase rTRD01 | rTRD01 cost | order rTRD01 | rTRD01 chemical structure | rTRD01 in vivo | rTRD01 in vitro | rTRD01 formula | rTRD01 molecular weight